Shiraz E-Medical Journal

Published by: Kowsar

Newly Defined Role of Pharmacoeconomics in Iran National Medicine Policy

Abdol Majid Cheraghali 1 , *
Author Information
1 Faculty of Pharmacy, Pharmaceutical Management and Economics Research Center (PMERC), Baqiyatallah University of Medical Sciences, Tehran, IR Iran
Article information
  • Shiraz E-Medical Journal: January 01, 2016, 17 (1); e35258
  • Published Online: January 27, 2016
  • Article Type: Editorial
  • Received: September 1, 2015
  • Revised: October 15, 2015
  • Accepted: November 15, 2015
  • DOI: 10.17795/semj35258

To Cite: Cheraghali A M. Newly Defined Role of Pharmacoeconomics in Iran National Medicine Policy, Shiraz E-Med J. 2016 ; 17(1):e35258. doi: 10.17795/semj35258.

Copyright © 2016, Shiraz University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
Acknowledgements
References
  • 1. Babar ZU, Scahill S. Is there a role for pharmacoeconomics in developing countries? Pharmacoeconomics. 2010; 28(12): 1069-74[DOI][PubMed]
  • 2. Bagheri Lankarani K, Alavian SM, Peymani P. Health in the Islamic Republic of Iran, challenges and progresses. Med J Islam Repub Iran. . 2013; 27: 42-9
  • 3. Davari M, Haycox A, Walley T. The Iranian health insurance system; past experiences, present challenges and future strategies. Iran J Public Health. 2012; 41(9): 1-9[PubMed]
  • 4. Implications of Pharmacoeconomics for Iran National Health System. Iran J Pharm Sci. 2013; 9: 81-5
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .
Readers' Comments